Vascular Grafts Market: By Product (Endovascular Stent Graft, Peripheral Vascular Graft, Others), By Source (Synthetic, Biological), By Application (Vascular Occlusion, Renal Failure, Coronary Artery Disease, and Others), By End User (Hospitals, Ambulatory Surgical Centers and Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Vascular Grafts Market size was valued at USD 2.29 billion in 2023 and expected to reach USD 3.42 billion by 2030, at a significant CAGR of 8.4% from 2024-2030.  A vascular graft is a tube-shaped synthetic material which is surgically implanted into the arteries or veins. These vascular grafts are used for vascular bypass operations or to create the vein access in hemodialysis patients. The size of the tube depends upon the size of the vein or artery replaced. Global vascular grafts market is primarily driven by the increase in the prevalence of vascular diseases due to lifestyle changes and food habit changes among the populace. In addition, prevalence of the end-stage renal diseases, hypertension, and cardiac arrhythmias is expected to boost the market share furthermore. Moreover, increase in alcohol consumption, and tobacco intake are leading to chronic diseases and are expected to increase the demand for vascular grafts over the forecast period. However, the low reimbursement rates and high cost of the procedures are projected to hamper the growth of the market over the coming years. 

Vascular Grafts Market Key Developments:

  • In April 2018, Terumo Aortic has launched thoracic stent graft system RelayPro to expand the treatment of endovascular aortic repair.
  • In January 2014, W.L. Gore & Associates Inc. has launched Acuseal Vascular Graft for vascular access.

Vascular Grafts Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.4%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Vascular Grafts Market Dynamics

Global vascular grafts market is expected to have significant growth rate owing to the increase in R&D in development of the new vascular grafts and expansion of applications. For instance, Medtronic has developed stent graft system Endurant II AAA to treat abdominal aortic aneurysm. Furthermore, market is very dynamic due to the presence of big and small regional market players. Companies are adopting the strategies such as mergers and acquisitions to expand the market share.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Vascular Grafts Market Segmentation

By Product Type
  • Bypass Graft
  • Endovascular Stent Graft
  • Peripheral Vascular Graft
  • Others
By Source
  • Synthetic
  • Biological
By Application
  • Vascular Occlusion
  • Renal Failure
  • Coronary Artery Disease
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The Vascular Grafts Market size was valued at USD 2.29 billion in 2023

The Vascular Grafts Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Vascular Grafts Market key players Becton, Dickinson & Company (U.S.), Medtronic (U.S.), Revolutions Medical Corporation (U.S.), Retractable Technologies, Inc. (U.S.), Royal Imtech N.V. (Smiths Medical) (Netherlands), Terumo Corporation (Japan), Unilife Corporation (U.S.), Sol-Millennium Medical Group (China), Ultimed, Inc. (U.S.), Axel Bio Corporation (U.S.)

1.Executive Summary
2.Global Vascular Grafts Market Introduction 
2.1.Global Vascular Grafts Market  - Taxonomy
2.2.Global Vascular Grafts Market  - Definitions
2.2.1.Product Type
2.2.2.Source
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Vascular Grafts Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Vascular Grafts Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Vascular Grafts Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Bypass Graft
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Endovascular Stent Graft
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Peripheral Vascular Graft
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Vascular Grafts Market  By Source, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Synthetic
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Biological
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Vascular Grafts Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Vascular Occlusion
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Renal Failure
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Coronary Artery Disease
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Vascular Grafts Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Ambulatory Surgical Centers
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Others
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Vascular Grafts Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Bypass Graft
10.1.2.Endovascular Stent Graft
10.1.3.Peripheral Vascular Graft
10.1.4.Others
10.2.  Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Synthetic
10.2.2.Biological
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Vascular Occlusion
10.3.2.Renal Failure
10.3.3.Coronary Artery Disease
10.3.4.Others
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Ambulatory Surgical Centers
10.4.3.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Bypass Graft
11.1.2.Endovascular Stent Graft
11.1.3.Peripheral Vascular Graft
11.1.4.Others
11.2.  Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Synthetic
11.2.2.Biological
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Vascular Occlusion
11.3.2.Renal Failure
11.3.3.Coronary Artery Disease
11.3.4.Others
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Ambulatory Surgical Centers
11.4.3.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Bypass Graft
12.1.2.Endovascular Stent Graft
12.1.3.Peripheral Vascular Graft
12.1.4.Others
12.2.  Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Synthetic
12.2.2.Biological
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Vascular Occlusion
12.3.2.Renal Failure
12.3.3.Coronary Artery Disease
12.3.4.Others
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Ambulatory Surgical Centers
12.4.3.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Bypass Graft
13.1.2.Endovascular Stent Graft
13.1.3.Peripheral Vascular Graft
13.1.4.Others
13.2.  Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Synthetic
13.2.2.Biological
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Vascular Occlusion
13.3.2.Renal Failure
13.3.3.Coronary Artery Disease
13.3.4.Others
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Ambulatory Surgical Centers
13.4.3.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Vascular Grafts Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Bypass Graft
14.1.2.Endovascular Stent Graft
14.1.3.Peripheral Vascular Graft
14.1.4.Others
14.2.  Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Synthetic
14.2.2.Biological
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Vascular Occlusion
14.3.2.Renal Failure
14.3.3.Coronary Artery Disease
14.3.4.Others
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Ambulatory Surgical Centers
14.4.3.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Becton, Dickinson & Company (U.S)
15.2.2.Medtronic (U.S)
15.2.3.Revolutions Medical Corporation (U.S)
15.2.4.Retractable Technologies, Inc. (U.S)
15.2.5.Royal Imtech N.V. (Smiths Medical) (Netherlands
15.2.6.Terumo Corporation (Japan)
15.2.7.Unilife Corporation (U.S)
15.2.8.Sol-Millennium Medical Group (China)
15.2.9.Ultimed, Inc. (U.S)
15.2.10.Axel Bio Corporation (U.S)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Becton, Dickinson & Company (U.S)
  • Medtronic (U.S)
  • Revolutions Medical Corporation (U.S)
  • Retractable Technologies, Inc. (U.S)
  • Royal Imtech N.V. (Smiths Medical) (Netherlands
  • Terumo Corporation (Japan)
  • Unilife Corporation (U.S)
  • Sol-Millennium Medical Group (China)
  • Ultimed, Inc. (U.S)
  • Axel Bio Corporation (U.S)

Adjacent Markets